Wound Care Innovations adds first pharmacy client to growing list of customers

NewsGuard 100/100 Score

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) announced today that its subsidiary Wound Care Innovations, LLC has added the company's first pharmacy client to its rapidly growing list of customers.  Lewis Hall, Inc. of Fort Worth, TX is an independent pharmacy group that has several locations and 30 years experience in wound care, long term care and specialty compounded products for dermatologic use.  Lewis Hall, company president, was quoted as saying, "We are genuinely excited about having Cellerate RX® as part of our product line. It has had such tremendous outcomes that we believe our customers will find it to be one of the best wound healing products in the market."

This order punctuates a string of recent successes for WCI in the 3rd Quarter resulting in the company having the best sales order quarter in its history, with one order for over $300,000 of products that will be shipped during the 4th quarter of 2010. WCI continues to surge ahead in the execution of its growth strategy highlighted by its expansion in the South African and Central American markets as well as in the government sector through its addition of Veterans Health Administration facilities in Texas and Florida as announced last month.

Ronald D. Mathis, Senior Vice President of Marketing and Sales said, "We understand that sales growth rarely happens at the pace that everyone would prefer. However, what we are seeing here is the focused execution of a highly developed plan that has the opportunity to yield phenomenal results for both Wound Management Technologies and its shareholders."

WNDM is filing a Form 8k today about recent company progress along with a presentation being made on October 7, 2010 to the investment community. 

For Wound Management Technologies Shareholder Information please call 817-820-7077 or go to http://www.wmgtech.com

Source:

Wound Management Technologies, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists develop 3D-printable gelatin materials for reconstructive and plastic surgery